SELLAS Announces Completion of Enrollment and Initial Positive Data in Phase 2a Trial of SLS009 in r/r AML
June 10, 2024 08:40 ET
|
SELLAS Life Sciences Group, Inc.
- 30 Patients Relapsed or Refractory to Venetoclax-Based Regimens Enrolled Ahead of Schedule - - Overall Response Rate (ORR) of 33% and 50% Achieved to Date in 60 mg QW and 30 mg BIW Cohorts,...
Rail Vision Successfully Installs AI-Driven System for Class 1 USA Operator
June 10, 2024 08:36 ET
|
Rail Vision Ltd.
Ra’anana, Israel, June 10, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related...
NewtekOne, Inc. CEO, Barry Sloane, to Attend the 25th Annual KBW Community Bank Investor Conference July 30-31, 2024
June 10, 2024 08:30 ET
|
NewtekOne, Inc.
BOCA RATON, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (Nasdaq: NEWT), announced today that NewtekOne’s CEO and President, Barry Sloane, and CFO, M. Scott Price, will attend and hold...
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan
June 10, 2024 08:30 ET
|
Surrozen, Inc.
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 at the 2024 European Association for the Study of the Liver (EASL) in Milan
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
June 10, 2024 08:30 ET
|
SeaStar Medical Holding Corporation
DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) announces that three new members have joined its Board of Directors. Two new directors,...
HF Foods Announces Settlement with SEC
June 10, 2024 08:30 ET
|
HF Foods Group Inc.
LAS VEGAS, June 10, 2024 (GLOBE NEWSWIRE) -- HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods”, or the “Company”), a leading food distributor to Asian restaurants across the United States, today...
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
June 10, 2024 08:30 ET
|
GeneDx Holdings Corp.
-- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections -- -- Increases commercial footprint and focus on...
SRM Announces Custom Designed Product Order for In-(Movie)Theater Marketplace
June 10, 2024 08:30 ET
|
SRM Entertainment, Inc.
JUPITER, FL, June 10, 2024 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc., (Nasdaq: SRM) (the “Company” or “SRM”) is pleased to announce a new order for SRM custom designed, nostalgic movie character...
Veru to Present at the American Diabetes Association's 84th Scientific Sessions
June 10, 2024 08:30 ET
|
Veru Inc.
MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in Barcelona
June 10, 2024 08:30 ET
|
Biodexa Pharmaceuticals PLC
June 10, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious...